谷歌浏览器插件
订阅小程序
在清言上使用

Brentuximab Vedotin In The Treatment Of Elderly Hodgkin Lymphoma Patients At First Relapse Or With Primary Refractory Disease: A Phase 2 Study Of Fil Onlus

HAEMATOLOGICA(2019)

引用 2|浏览55
暂无评分
关键词
Cell Therapy and Immunotherapy,Hodgkin's Lymphoma,brentuximab vedotin,elderly
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要